Join to View Full Profile
525 E 68th St# 69New York, NY 10065
Phone+1 646-253-2808
Fax+1 212-746-3856
Dr. Skerrett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Columbia UniversityMSC, Public Health-BioStatistics, 2001 - 2003
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1987 - 1989
Baylor College of MedicineResidency, Internal Medicine, 1984 - 1987
Lewis Katz School of Medicine at Temple UniversityClass of 1984- University of PennsylvaniaBA, Biology, 1975 - 1979
Certifications & Licensure
NY State Medical License 1988 - 2028
NJ State Medical License 2003 - 2009
American Board of Internal Medicine Internal Medicine
American Board of Pathology Blood Banking/Transfusion Medicine
Clinical Trials
- Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF) Start of enrollment: 2007 Oct 01
- Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction Start of enrollment: 2008 Mar 01
- Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion Start of enrollment: 2008 Nov 01
Publications & Presentations
PubMed
- 126 citationsA Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who F...Joanne Kurtzberg, Hisham Abdel-Azim, Paul A. Carpenter, Sonali Chaudhury, Biljana Horn
Biology of Blood and Marrow Transplantation. 2020-05-01 - 126 citationsA Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host DiseasePartow Kebriaei, Jack Hayes, Andrew Daly, Joseph P. Uberti, David I. Marks
Biology of Blood and Marrow Transplantation. 2020-05-01 - 5 citationsThe significance of a positive DAT in thalassemia patients.Suzanne A. Arinsburg, Donna Skerrett, Dorothy A. Kleinert, Patricia J. Giardina, Melissa M. Cushing
Immunohematology. 2020-01-01
Press Mentions
Paradigm Achieves Primary Endpoint in PARA_OA_008 Synovial Fluid Biomarker Phase 2 Clinical TrialOctober 6th, 2022- Paradigm Doses First Subjects in Phase III Knee Osteoarthritis TrialMay 5th, 2022
- First Subjects Randomized and Dosed in the U.S. Under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OAMay 4th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
